Salivary gland infection market to reach $6.49 billion by 2030 at 7.8% CAGR

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Salivary Gland Infection Market Grow Between 2026 And 2030?

The salivary gland infection market size has seen substantial growth in recent years. It is forecast to increase from $4.45 billion in 2025 to $4.81 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.1%. This historical expansion can be attributed to the increasing incidence of bacterial and viral salivary infections, improved access to diagnostic imaging, the availability of broad-spectrum antibiotics, the expansion of hospital-based ENT services, and rising clinical awareness of gland disorders.

The salivary gland infection market is poised for significant expansion in the coming years, with its size projected to reach $6.5 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. This growth during the forecast period is attributed to factors such as increasing demand for advanced diagnostic accuracy, a rise in investments in ENT diagnostic tools, the expansion of outpatient diagnostic services, a growing emphasis on patient-centric treatment pathways, and the increased integration of imaging with laboratory diagnostics. Major trends anticipated in this period include the wider use of advanced imaging diagnostics, the rising adoption of targeted antibiotic therapies, an increased focus on early infection detection, the expansion of minimally invasive treatment approaches, and an enhanced emphasis on comprehensive diagnostic pathways.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21281&type=smp

Which Key Factors Are Driving The Salivary Gland Infection Market Growth?

The growth of the salivary gland infections market is anticipated to be propelled by an increase in oral health concerns. Such concerns encompass conditions like tooth decay, gum diseases, and various other mouth-related ailments. These escalating oral health issues stem from factors such as insufficient oral hygiene, detrimental eating patterns, and limited access to proper dental care. An uptick in these problems heightens the risk of salivary gland infections by fostering bacterial proliferation and obstructions within the salivary ducts. For example, the National Health Service (NHS), a UK-based government agency, reported in May 2024 that 32.5 million dental treatments were administered in 2022-23, marking a 23.2% rise from the preceding year. Consequently, the rising prevalence of oral health issues is fostering the expansion of the salivary gland infections market.

Salivary Gland Infection Market Driver: Surge In Minimally Invasive Surgery Fueling The Growth Of The Market Due To Rising Preference For Faster And Safer Treatment Options

What Are The Key Segment Divisions In The Salivary Gland Infection Market Segment Structure?

The salivary gland infection market covered in this report is segmented –

1) By Diagnosis: Plain Radiography, Sialography, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Radionuclide Scintigraphy, High-resolution Ultrasonography, Other Diagnoses

2) By Treatment: Medications, Surgery, Aspiration, Home Care, Other Treatments

3) By End User: Hospitals And Clinics, Medical Research Centers, Academic Institutes, Other End User

Subsegments:

1) By Plain Radiography: X-ray Of Salivary Glands, Sialography With X-ray

2) By Sialography: Conventional Sialography, Digital Subtraction Sialography (DSS)

3) By Computed Tomography (CT): Non-contrast CT, Contrast-enhanced CT

4) By Magnetic Resonance Imaging (MRI): MRI without contrast, MRI With contrast (Dynamic MRI)

5) By Radionuclide Scintigraphy: Planar Scintigraphy, SPECT (Single Photon Emission Computed Tomography)

6) By High-resolution Ultrasonography: Standard Ultrasonography, Doppler Ultrasonography

7) By Other Diagnoses: Fine Needle Aspiration (FNA) Biopsy, Endoscopy, Salivary Flow Test

Which Trends Are Guiding The Direction Of The Salivary Gland Infection Market?

Major corporations active in the salivary gland infections market are prioritizing technological advancements, particularly in minimally invasive techniques, to enhance treatment outcomes, expedite patient recovery, and improve overall healthcare efficiency. Minimally invasive methods involve smaller cuts and specialized instruments, leading to less tissue damage and promoting quicker healing. For example, in March 2024, Amrita Hospital, an India-based medical institution, inaugurated the Amrita Centre for minimally invasive salivary gland surgery, providing a novel endoscopic treatment for salivary disorders that reduces the need for extensive surgery and preserves glandular function. This launch was highlighted by a two-day workshop featuring expert demonstrations.

Which Organizations Are Engaged In The Salivary Gland Infection Market?

Major companies operating in the salivary gland infection market are Pfizer Inc., Johnson And Johnson, Roche Holding AG, Merck And Co Inc, AbbVie Inc, AstraZeneca plc, Novartis AG, GSK plc, Eli Lilly And Company, FUJIFILM Holdings Corporation, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Astellas Pharma Inc, Sandoz International GmbH, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc, Mylan NV, Zydus Cadila Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Dr Reddys Laboratories Ltd, Cipla Limited, Sanofi SA, Bayer AG, Perrigo Company plc

Get The Full Salivary Gland Infection Market Report:

https://www.thebusinessresearchcompany.com/report/salivary-gland-infection-global-market-report

Which Region Is The Largest In The Salivary Gland Infection Market?

North America was the largest region in the salivary gland infection market in 2025. The regions covered in the salivary gland infection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Salivary Gland Infection Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/salivary-gland-infection-global-market-report

Browse Through More Reports Similar to the Global Salivary Gland Infection Market 2026, By The Business Research Company

Covid 19 Saliva Screening Test Potential Market Report 2026

https://www.thebusinessresearchcompany.com/report/covid-19-saliva-screening-test-potential-global-market-report

Oral Hygiene Market Report

https://www.thebusinessresearchcompany.com/report/oral-hygiene-global-market-report

Ear Infection Market Report

https://www.thebusinessresearchcompany.com/report/ear-infection-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795